Mark Anczurowski
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Immunology 14
- Immune Cell Function and Interaction 13
- T-cell and B-cell Immunology 8
- Immunotherapy and Immune Responses 4
- Oncology 10
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Naoto Hirano (15 shared papers)Marcus O. Butler (14 shared papers)Yuki Kagoya (13 shared papers)Tingxi Guo (14 shared papers)Kayoko Saso (13 shared papers)Chung-Hsi Wang (9 shared papers)Mark D. Minden (2 shared papers)Shinya Tanaka (2 shared papers)
- Journals
- Scientific Reports (2 papers)Journal of Autoimmunity (2 papers)Nature Communications (2 papers)Annals of Oncology (1 paper)Nature Medicine (1 paper)
- Partner nations
- CanadaJapanUnited States
In The Last Decade
Mark Anczurowski
16 papers receiving 931 citations
Mark Anczurowski's Hit Papers
Peers
Comparison fields: 5 of 50
- Oncology 735
- Immunology 443
- Genetics 204
- Molecular Biology 368
- Biomedical Engineering 211
Countries citing papers authored by Mark Anczurowski
This map shows the geographic impact of Mark Anczurowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Anczurowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Anczurowski more than expected).
Fields of papers citing papers by Mark Anczurowski
This network shows the impact of papers produced by Mark Anczurowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Anczurowski. The network helps show where Mark Anczurowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Anczurowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects Hit paper breakdown → | 2018 | 446 |
| 2 | 2016 | 168 | |
| 3 | 2020 | 126 | |
| 4 | 2017 | 44 | |
| 5 | 2018 | 38 | |
| 6 | 2017 | 29 | |
| 7 | 2018 | 22 | |
| 8 | 2017 | 18 | |
| 9 | 2018 | 14 | |
| 10 | 2021 | 14 | |
| 11 | 2016 | 12 | |
| 12 | 2018 | 7 | |
| 13 | 2016 | 4 | |
| 14 | 2019 | 2 | |
| 15 | 2022 | 2 | |
| 16 | 2016 | 2 |
About Mark Anczurowski
Mark Anczurowski is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 16 papers that have together received 948 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (9 papers), T-cell and B-cell Immunology (8 papers), Immunotherapy and Immune Responses (4 papers), Virus-based gene therapy research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Pancreatic function and diabetes (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Oncology (735 citations), Immunology (443 citations), Genetics (204 citations), Molecular Biology (368 citations) and Biomedical Engineering (211 citations). Mark Anczurowski has collaborated with scholars based in Canada, Japan and United States. Frequent co-authors include Naoto Hirano, Marcus O. Butler, Yuki Kagoya, Tingxi Guo, Kayoko Saso, Chung-Hsi Wang, Mark D. Minden, Shinya Tanaka, Munehide Nakatsugawa and Toshiki Ochi. Their work appears in journals such as Scientific Reports, Journal of Autoimmunity, Nature Communications, Annals of Oncology and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.